AAAAAA
Results:
1-22
|
Results: 22
Authors:
Hauschild, A
Oratz, R
Sebastian, G
Citation: A. Hauschild et al., Intratumoral cisplatin/epinephrine injectable gel for treatment of patients with cutaneous and soft tissue metastases of malignant melanoma: an international Multicenter study (vol 11, pg S223, 2001), MELANOMA RE, 11(2), 2001, pp. 203-203
Authors:
Hauschild, A
Christophers, E
Citation: A. Hauschild et E. Christophers, Sentinel node biopsy in melanoma, VIRCHOWS AR, 438(2), 2001, pp. 99-106
Authors:
Reifenberger, J
Arnold, N
Kiechle, M
Reifenberger, G
Hauschild, A
Citation: J. Reifenberger et al., Coincident PTCH and BRCA1 germline mutations in a patient with nevoid basal cell carcinoma syndrome and familial breast cancer, J INVES DER, 116(3), 2001, pp. 472-474
Authors:
Lischner, S
Dunsche, A
Hauschild, A
Citation: S. Lischner et al., Congenital cerebriform melanocytic nevus on the scalp. Removal after tissue expander implantation, HAUTARZT, 52, 2001, pp. 952-955
Authors:
Hauschild, A
Eiling, S
Lischner, S
Haacke, TC
Christophers, E
Citation: A. Hauschild et al., Safety margins for the primary surgical excison of malignant melanoma. Proposals based on controlled clinical trials, HAUTARZT, 52(11), 2001, pp. 1003-1010
Authors:
Hauschild, A
Moller, M
Lischner, S
Christophers, E
Citation: A. Hauschild et al., Repeatable acute rhabdomyolysis with multiple organ dysfunction because ofinterferon a and dacarbazine treatment in metastatic melanoma, BR J DERM, 144(1), 2001, pp. 215-216
Authors:
Hauschild, A
Garbe, C
Stolz, W
Ellwanger, U
Seiter, S
Dummer, R
Ugurel, S
Sebastian, G
Nashan, D
Linse, R
Achtelik, W
Mohr, P
Kaufmann, R
Fey, M
Ulrich, J
Tilgen, W
Citation: A. Hauschild et al., Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG), BR J CANC, 84(8), 2001, pp. 1036-1042
Authors:
Hauschild, A
Lischner, S
Christophers, E
Citation: A. Hauschild et al., Surgical and systemic adjuvant treatment of head and neck primary melanoma., LARY RH OTO, 79(7), 2000, pp. 428-433
Authors:
Hauschild, A
Volkenandt, M
Garbe, C
Citation: A. Hauschild et al., Adjuvant drug treatment of malignant melanoma, DEUT MED WO, 125(42), 2000, pp. 1272-1278
Authors:
Schmitz, C
Brenner, W
Henze, E
Christophers, E
Hauschild, A
Citation: C. Schmitz et al., Comparative study on the clinical use of protein S-100B and MIA (melanoma inhibitory activity) in melanoma patients, ANTICANC R, 20(6D), 2000, pp. 5059-5063
Authors:
Bosserhoff, AK
Hauschild, A
Hein, R
Schadendorf, D
Stockfleth, E
Bogenrieder, T
Landthaler, M
Buettner, R
Stolz, W
Citation: Ak. Bosserhoff et al., Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: Results of a German multicenter study, J INVES DER, 114(2), 2000, pp. 395-396
Authors:
Hauschild, A
Citation: A. Hauschild, High-dosage interferon-alpha-2b therapy - Position of the Dermatological Oncology Research Group - Reply, HAUTARZT, 51(5), 2000, pp. 362-362
Authors:
Hauschild, A
Hinrichsen, H
Christophers, E
Citation: A. Hauschild et al., Side effects of interferon therapy and their management, HAUTARZT, 51(10), 2000, pp. 793-803
Authors:
Rudolph, P
Schubert, C
Tamm, S
Heidorn, K
Hauschild, A
Michalska, I
Majewski, S
Krupp, G
Jablonska, S
Parwaresch, R
Citation: P. Rudolph et al., Telomerase activity in melanocytic lesions - A potential marker of tumor biology, AM J PATH, 156(4), 2000, pp. 1425-1432
Authors:
Hauschild, A
Michaelsen, J
Brenner, W
Glaser, R
Henze, E
Christophers, E
Citation: A. Hauschild et al., Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients, MELANOMA RE, 9(2), 1999, pp. 155-161
Authors:
Hauschild, A
Lange, HJ
Spitzer, HJ
Citation: A. Hauschild et al., Scale separation of weather and climate using the example of horizontal transports, METEOROL Z, 8(4), 1999, pp. 115-131
Authors:
Kroger, H
Hauschild, A
Ohde, M
Bache, K
Voigt, WP
Ehrlich, W
Citation: H. Kroger et al., Enhancing the inhibitory effect of nicotinamide upon collagen II induced arthritis in mice using N-acetylcysteine, INFLAMMATIO, 23(2), 1999, pp. 111-115
Authors:
Kroger, H
Hauschild, A
Ohde, M
Bache, K
Voigt, WP
Thefeldt, W
Kruger, D
Citation: H. Kroger et al., Nicotinamide and methionine reduce the liver toxic effect of methotrexate, GEN PHARM, 33(2), 1999, pp. 203-206
Authors:
Hauschild, A
Engel, G
Brenner, W
Glaser, R
Monig, H
Henze, E
Christophers, E
Citation: A. Hauschild et al., S100B protein detection in serum is a significant prognostic factor in metastatic melanoma, ONCOL-BASEL, 56(4), 1999, pp. 338-344
Authors:
Becker, J
Brocker, EB
Dummer, R
Enk, A
Garbe, C
Hauschild, A
Hein, R
Kaufmann, R
Krahn, G
Lohmann, F
Luther, H
Mauch, C
Mohr, P
Nashan, D
Neuber, K
Peter, RU
Reinhold, U
Schadendorf, D
Sebastian, G
Soyer, P
Stadler, R
Stolz, W
Tilgen, W
Trefzer, U
Tronnier, M
Ulrich, J
Volkenandt, M
Citation: J. Becker et al., Current position of the Working Group on Dermatological Oncology on high-dose therapy with interferon alpha 2b, HAUTARZT, 50(6), 1999, pp. 395-397
Authors:
Hauschild, A
Engel, G
Brenner, W
Glaser, R
Monig, H
Henze, E
Christophers, E
Citation: A. Hauschild et al., Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and or immunotherapy, BR J DERM, 140(6), 1999, pp. 1065-1071
Authors:
Hauschild, A
Swensson, O
Christophers, E
Citation: A. Hauschild et al., Paraneoplastic bullous pemphigoid resembling erythema gyratum repens, BR J DERM, 140(3), 1999, pp. 550-552
Risultati:
1-22
|